INTRODUCTIONImmunosuppression, as seen in solid organ transplant recipients (SOTRs), has been highly associated with the development of cutaneous keratinocyte carcinomas (KCs), particularly squamous cell carcinomas (SCCs) and basal cell carcinomas…
Read More
INTRODUCTIONNivolumab is a human immunoglobulin monoclonal antibody IgG4 that binds to and thus blocks the programmed death (PD-1) receptor, and ipilimumab is a monoclonal antibody against CTL antigen 4 (CTLA-4).…
Read More
INTRODUCTIONOn histologic interpretation during MMS, the authors observed numerous areas of incompletely stained tissue where cellular architecture was preserved, but obscured by an amorphous, eosinophilic artifact that eliminated contrast between…
Read More
INTRODUCTION Nonmelanoma skin cancer (NMSC) is a common cancer with an annual incidence in the United States of over 3 million new diagnoses.1,2 There are 2 major subtypes: basal cell…
Read More
INTRODUCTIONRecent events highlight disparities for skin of color (SOC) patients in dermatology. These disparities affect the care received by SOC patients. One determinant of outcome and degree of comfort for…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a highly prevalent chronic immune-mediated disorder of the skin that affects populations globally. Although the role of race and ethnicity in the pathophysiology of AD remains…
Read More
INTRODUCTIONCase Synopsis A 45-year-old woman presented with a one-year history of a growing mass on the scalp. The patient believed the lesion was a benign cyst and requested removal due…
Read More
INTRODUCTIONAtopic Dermatitis (AD) is a chronic inflammatory skin condition affecting children and adults of all races and ethnicities.1-3 AD commonly presents with eczematous and pruritic skin lesions. These lesions can…
Read More
INTRODUCTIONGiant basal cell carcinoma (GBCC), a tumor >5 cm in diameter, is a rare subgroup of basal cell carcinoma (BCC) comprising < 1% of all cases.1 Typically, GBCC is associated…
Read More
INTRODUCTIONInitial uncertainty during the COVID-19 pandemic led most medical organizations to recommend postponing all nonessential visits.1 Unfortunately for patients with newly diagnosed skin cancers, many Mohs surgeries were included in…
Read More
INTRODUCTIONDiabetes is one of the leading causes of death and disability in the United States, with an estimated global prevalence of 9.3% in 2019.1,2 The development of skin cancer is…
Read More
INTRODUCTIONThe introduction of soft tissue augmentation with injectable dermal fillers has revolutionized the aesthetics market and is now an eminent routine procedure. An array of filler products is currently available…
Read More
